NAM Biotech Fund II, LLC - Series II — Form D
NAM Biotech Fund II, LLC - Series II of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2017-04-27. The offering totals $40.0M. Industry: Pooled Investment Fund.
Offering
- Filed: 2017-04-27
- Form: D
- Accession: 0000905718-17-000497
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $40.0M
- Remaining: $40.0M
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-285671
Issuer
- Name: NAM Biotech Fund II, LLC - Series II
- CIK: 0001704222
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 410 PARK AVENUE, 14TH FLOOR, NEW YORK, NY, 10022
- Phone: 212-417-8033
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| David Levine | Executive Officer | Martinsburg, WV |
| - NAM Biotech Management LLC | Executive Officer | New York, NY |
| - National Asset Management, Inc. | Executive Officer | New York, NY |
More